Svane IM - Search Results

1

Vaccination with p53 peptide-pulsed dendritic cells is associated with disease stabilization in patients with p53 expressing advanced breast cancer; monitoring of serum YKL-40 and IL-6 as response biomarkers.

Svane IM, Pedersen AE, Johansen JS, Johnsen HE, Nielsen D, Kamby C, Ottesen S, Balslev E, Gaarsdal E, Nikolajsen K, Claesson MH. Svane IM, et al. Cancer Immunol Immunother. 2007 Sep;56(9):1485-99. doi: 10.1007/s00262-007-0293-4. Epub 2007 Feb 7. Cancer Immunol Immunother. 2007. PMID: 17285289 Free PMC article. Clinical Trial.

2

Impact of high-dose chemotherapy on antigen-specific T cell immunity in breast cancer patients. Application of new flow cytometric method.

Svane IM, Nikolajsen K, Hansen SW, Kamby C, Nielsen DL, Johnsen HE. Svane IM, et al. Bone Marrow Transplant. 2002 Apr;29(8):659-66. doi: 10.1038/sj.bmt.1703521. Bone Marrow Transplant. 2002. PMID: 12180110

3

Clinical application of dendritic cells in cancer vaccination therapy.

Svane IM, Soot ML, Buus S, Johnsen HE. Svane IM, et al. APMIS. 2003 Jul-Aug;111(7-8):818-34. doi: 10.1034/j.1600-0463.2003.11107813.x. APMIS. 2003. PMID: 12974783 Review.

4

Acute and late toxicity following adjuvant high-dose chemotherapy for high-risk primary operable breast cancer--a quality assessment study.

Svane IM, Homburg KM, Kamby C, Nielsen DL, Roer O, Sliffsgaard D, Johnsen HE, Hansen SW. Svane IM, et al. Acta Oncol. 2002;41(7-8):675-83. Acta Oncol. 2002. PMID: 14651213

5

Vaccination with p53-peptide-pulsed dendritic cells, of patients with advanced breast cancer: report from a phase I study.

Svane IM, Pedersen AE, Johnsen HE, Nielsen D, Kamby C, Gaarsdal E, Nikolajsen K, Buus S, Claesson MH. Svane IM, et al. Cancer Immunol Immunother. 2004 Jul;53(7):633-41. doi: 10.1007/s00262-003-0493-5. Epub 2004 Feb 25. Cancer Immunol Immunother. 2004. PMID: 14985857 Free PMC article. Clinical Trial.

6

Impaired circulating myeloid DCs from myeloma patients.

Do TH, Johnsen HE, Kjaersgaard E, Taaning E, Svane IM. Do TH, et al. Among authors: svane im. Cytotherapy. 2004;6(3):196-203. doi: 10.1080/14653240410006004. Cytotherapy. 2004. PMID: 15203976

7

Immunogenicity of Bcl-2 in patients with cancer.

Andersen MH, Svane IM, Kvistborg P, Nielsen OJ, Balslev E, Reker S, Becker JC, Straten PT. Andersen MH, et al. Among authors: svane im. Blood. 2005 Jan 15;105(2):728-34. doi: 10.1182/blood-2004-07-2548. Epub 2004 Sep 14. Blood. 2005. PMID: 15367432 Free article.

8

[High dose chemotherapy versus conventional chemotherapy in metastasing breast cancer. An analysis of a systematic Cochrane review].

Nielsen DL, Svane IM. Nielsen DL, et al. Among authors: svane im. Ugeskr Laeger. 2004 Nov 8;166(46):4145-7. Ugeskr Laeger. 2004. PMID: 15565848 Danish. No abstract available.

9

[High dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional chemotherapy in primary breast cancer. An analysis of a systematic Cochrane review].

Nielsen DL, Svane IM. Nielsen DL, et al. Among authors: svane im. Ugeskr Laeger. 2004 Nov 8;166(46):4148-50. Ugeskr Laeger. 2004. PMID: 15565849 Danish. No abstract available.

10

Spontaneous T-cell responses against peptides derived from the Taxol resistance-associated gene-3 (TRAG-3) protein in cancer patients.

Meier A, Reker S, Svane IM, Holten-Andersen L, Becker JC, Søndergaard I, Andersen MH, Thor Straten P. Meier A, et al. Among authors: svane im. Cancer Immunol Immunother. 2005 Mar;54(3):219-28. doi: 10.1007/s00262-004-0578-9. Epub 2004 Oct 2. Cancer Immunol Immunother. 2005. PMID: 15580499 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

317 results

Search Page